AZD0516
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AZD0516, covering 2026-04-08 to 2026-04-08. Get the full timeline:
Most recent: Clinical Trial Update: Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer [Phase 1, Phase 2]